Medtronic Neuro
Clinical trials sponsored by Medtronic Neuro, explained in plain language.
Division of Medtronic focused on neurological devices and therapies.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Scientists wire up pelvic nerves to decode bladder and bowel disorders Results expected Dec 2026 (estimated)
- Brain implant that learns: new hope for Parkinson's? Results expected Jan 2027 (estimated)
-
Brain implant study aims to cut seizures in epilepsy patients
Disease control Stopped earlyThis study tested a brain implant (deep brain stimulation) to reduce seizures in 29 adults with epilepsy whose seizures were not controlled by medication. Participants kept diaries to track seizure frequency over three years. The goal was to see if the device safely and effective…
Sponsor: MedtronicNeuro • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
App-Based study aims to improve chronic pain tracking
Knowledge-focused Stopped earlyThis study looked at using a mobile app to collect feedback from 91 adults with chronic pain who were already receiving spinal cord stimulation (SCS) therapy. The goal was to see how well the app worked for gathering information on their pain and overall improvement. The study di…
Sponsor: MedtronicNeuro • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC